These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 33140822)
1. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles. Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453 [TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing. Duan F; Li H; Liu W; Zhao J; Yang Z; Zhang J Am J Med Sci; 2021 Aug; 362(2):173-181. PubMed ID: 34303519 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma. Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915 [TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers. Zhang C; Ren X; Liu Z; Tu C BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135 [TBL] [Abstract][Full Text] [Related]
6. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis. Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413 [TBL] [Abstract][Full Text] [Related]
7. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis. Wang J; Zhong P; Hua H Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548 [TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis. Liang C; Liu J; Ge H; Xu Y; Li G; Wu J Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540 [TBL] [Abstract][Full Text] [Related]
9. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma. Ren W; Zhu Z; Wu L J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532 [TBL] [Abstract][Full Text] [Related]
10. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers. Hu Q; Tai S; Wang J Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data. Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis. Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915 [TBL] [Abstract][Full Text] [Related]
13. [FOXD2-AS1 is corelated with clinicopathological parameter of laryngeal carcinoma and promote cancer cell proliferation]. Chen W; Sun SG; Jiang MX; Li SS; Yuan K Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 33(5):436-440. PubMed ID: 31163553 [No Abstract] [Full Text] [Related]
14. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors. Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939 [TBL] [Abstract][Full Text] [Related]
15. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches. Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis. Zhong P; Hua H; Chen S; Zhu Z; Xie F Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713 [TBL] [Abstract][Full Text] [Related]
18. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets. Shu Q; Liu X; Yang J; Mou T; Xie F Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152 [TBL] [Abstract][Full Text] [Related]
19. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis. Tian S; Liu J; Kong S; Peng L Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606 [TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1. Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]